Article
Life-long hydroxyurea treatment decreases chronic pain in sickle cell disease mice
2025-09-03
Abstract excerpt
Chronic sickle cell disease (SCD) pain mechanisms remain critically understudied, even though more than 50% of patients develop this symptom as their disease progresses. Despite high face validity, there are critical gaps in transgenic SCD mouse model characterization and implementation that must be addressed in order to increase the translational relevance of these animals. First, it is unclear when the chronic p...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d9d2cc13-c34d-5918-8e56-26e39527820e
- DOI
- 10.1101/2025.08.30.673263
